Vol 2014, No 2 (2014)

Table of Contents

Research & Development

Biogen Idec Enters Genome-Editing Field with Sangamo BioSciences Collaboration Abstract
Heather Cartwright
Santaris’ RNA-Targeting Platform Delivers Three Deals in Three Days Abstract
Heather Cartwright
Edison and Dainippon Sumitomo Broaden Relationship with Discovery Alliance Targeting Redox Biochemistry Abstract
Heather Cartwright
Ablynx and Merck & Co. Expand Alliance with US$2.3 B Cancer Immunotherapy Discovery Deal Abstract
Heather Cartwright

Licensing

Genzyme Invests US$700 M in Alnylam in Sign of Resurgent Interest in RNAi Therapeutics Abstract
Heather Cartwright

Mergers & Acquisitions

The Carlyle Group Offers US$4.15 B for J&J’s Ortho-Clinical Diagnostics Abstract
Heather Cartwright
Par Pharmaceutical Targets US Injectables Market with JHP Pharmaceuticals Purchase Abstract
Heather Cartwright
Teva Outbids Endo to Secure NuPathe Acquisition Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.